Cardiohemodynamic effects of BAY a 1040 in the dog.
D000284:Administration, Oral; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D003998:Dicarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005263:Femoral Artery / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007275:Injections, Intravenous; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects; D009578:Nitrobenzenes / Q000008:administration & dosage / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology*; D012077:Renal Artery / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D003998:Dicarboxylic Acids; D009578:Nitrobenzenes; D011725:Pyridines; D014665:Vasodilator Agents